The head and neck cancer immune landscape and its immunotherapeutic implications

Recent clinical trials have demonstrated a clear survival advantage in advanced head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint blockade. These emerging results reveal that HNSCC is one of the most promising frontiers for immunotherapy research. However, further...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JCI Insight
Egile Nagusiak: Mandal, Rajarsi, Şenbabaoğlu, Yasin, Desrichard, Alexis, Havel, Jonathan J., Dalin, Martin G., Riaz, Nadeem, Lee, Ken-Wing, Ganly, Ian, Hakimi, A. Ari, Chan, Timothy A., Morris, Luc G.T.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Clinical Investigation 2016
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070962/
https://ncbi.nlm.nih.gov/pubmed/27777979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.89829
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak